chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received 2 doses of vaccine on 1/6/21 and 2/1/21 and tested positive for Covid on 3/26/21
Information has been received from a nurse practitioner, referring to a 63 year old male patient. Information about medical history, concurrent condition and concomitant therapy was unknown. On an unknown date, the patient was vaccinated with improperly stored PNEUMOVAX 23 (dose, strength and frequency were unknown; lot# N014946, expiration date: 01-FEB-2019) intramuscular injection for prophylaxis. No adverse effects were reported. Temperature excursion was reported as 21 Fahrenheit (F) degrees for 1 hour and 30 minutes (1 cycle). There was no previous temperature excursion. A digital data logger was involved.
erythematous, warm area at the injection site treated with Benadryl and cool compress
My left arm developed a large lump (approx. bocce ball sized) and my arm was very warm to the touch. There was a distinction between the lump and my baseline skin.; I also felt very exhausted.; arm was very warm to the touch; This is a spontaneous report from a contactable consumer (patient).   A 29-Year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number: EN5318) on 02Feb2021 at 01:15 PM in left arm and first dose (Batch/Lot Number: EL1284) on 12Jan2021 at 01:15 PM in right arm via intramuscular route of administration as a single dose for covid-19 immunisation. The medical history was not reported. Concomitant medications included spironolactone, Tylenol and Ibuprofen. Patient had taken other vaccine in four weeks for Flu Shot on 28Dec2020 in left arm. Patient had Covid prior vaccination. And patient was not tested for Covid post vaccination. On 03Feb2021 at 05:30 AM patient felt that left arm developed a large lump (approx. bocce ball sized) and arm was very warm to the touch. There was a distinction between the lump and my baseline skin. She also felt very exhausted. The patient did not receive any treatment. The outcome of the event was recovered.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51-year-old male patient received BNT162b2 (BNT162B2), on 01Sep2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 51 years for covid-19 immunisation. The patient's relevant medical history included: "Bladder cancer" (unspecified if ongoing). Concomitant medication(s) included: FAMOTIDINE; ESOMEPRAZOLE; LEVOCETIRIZINE. The patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 09Jan2023 to 13Jan2023.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt c/o trouble swallowing 45 min after receiving flu shot. No other c/o. No local reaction. VSS, gave 2 children's benadryl fast use and take VSS 20 min later. Pt refused further Tx. Instructions given to call 911 if symptoms worsen. Pt stable 1.5 hours after flu injection given.
Patient had pneumonia vaccine on 9/18/08.  On 9/19/08 contacted office, area raised, warm and reddened.  Patient also complained of pain.  Patient instructed to take Benadryl and Rx for ultram given.
Patient started experiencing a moderate headache and a metallic taste in her mouth about 1.5 hours after receiving her Moderna Booster. She described the metallic taste as "pennies in her mouth". She is also experiencing a metallic smell.
During a review of the facility's internal records, it was found that there might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
shortly after second injection I got a double ear ache. Went through two rounds of antibiotics and drops and the problem persists. The doctors say I don't have an infection but my left ear still hurts most of the time and feels like there's something stuck way down in the ear canal.
Information has been received from a 25-year-old female pharmacy technician who reported that on 10-SEP-2008, she received the second dose of GARDASIL (lot # not reported) 0.5 mL via intramuscular route in her left deltoid. Concomitant medication included ORTHO-CYCLEN. According to the reporter, on 11-SEP-2008 she developed two "fluid filled blisters on either side of the site of injection" after the second dose of vaccination. The patient also experienced nausea and diarrhea. She sought unspecified medical attention. At the time of reporting, the patient had not recovered from the events. The patient's received her first dose of GARDASIL on 03-JUN-2008. Additional information has been requested.
Complained of deep muscle aches in arms, shoulders and upper thighs.  Of most important to note, patient has uncontrollable muscle twitching in one of the muscle bellies of the triceps muscle.  Patient shows that the vaccine was given in the deltoid by pointing to the site.  The twitching is distal to the injection site.  The twitching is visually noticable.
11:00AM A few bumps 5mm were noted on child abdomen and back, 1st child stated that was itchy. Child's eyes were red, slightly swollen and watery, face was red with a rash. Child started coughing and nose was running. Bumps extended to hives in abdomen and back. Skin was getting red all over body. 11:10AM Benadryl 0.44cc IM received. 11:30AM hives resolved.
About a week of receiving my vaccine, I had a fever of 101F, cough, sore throat, runny nose, sneezing, watery eyes, headache, and loss of appetite for a couple of days. I was concerned of my symptoms especially after just receiving my recent booster so I took an at-home COVID-19 test which came back positive on 09/20/2022. I sent a picture of my results to my doctor who later contacted me. We discussed the Paxlovid prescription, but my doctor was concerned about the potential rebound COVID-19 that many people were catching after recovering. So she prescribed Mucinex, Flonase, Neti Pot, and heavy fluids and Tylenol for the headaches and sore throat. Each day since contracting it, the fever and headache have began to subside, but I'm still having the runny nose and cough.
Abdominal pain starting around 5/14/21, tumor discovered 05/25/21, tumor was leiomyosarcoma.  Not sure if adverse event could be related.
Very  painful mensural cycle, fever, abnormal abdominal pain, muscle aches and joint pain. I typically have bad cycles with pain, but this is on another leave, and Advil is not working.
Left arm redness edema, heat, itch and pain extending from injection site in upper arm to the wrist. Unable to touch anterior arm due to pain. Fever of 102 degrees that night followed by four days of temps. Saw PCP, no treatment rendered.
patient developed DVT and stroke on 4/8 however she had been in hospital from 3/31 to 4/5 with SMART syndrome and L sided weakness .  after discharge she was inactive.  returned to hospital on 4/8 with stroke in the region of SMART syndrome.  Smart syndrome can cause stroke, but does not cause DVT.   platelets are normal.
High pitched scream 4-5 hrs 3pm-8; inconsolable crying 4-5 hrs 3PM-7 or 8;
Approximately 24 hrs after vaccine administration pt's left upper arm became red, edematous, and gender. Temp of 101.8. Pt. returned to healthcare clinic on 9/15/13 placed on antibiotics, steroids, and antihistamine. Follow-up phone call 9/16/13. Pt's arm is improviing.
Fever( ranging between 103.00F - 100.9); Took Tylenol 500 mg tablets single tablet twice in day for 2 days Body ache Joint pains(especially knees) Burning sensation internally in abdomen(like something gastric) Nausea  Diarrhea after 48hrs
Pt brought into clinic by Mother. Pt broke out in hives same day as receiving IZ's. No other possible potential cause for hives identified. No new foods, soaps or other medications, etc.
Patient had come to the drop off window and was complaining about side effects that she had after receiving her Shingles vaccine on 11/02/20. Patient was Spanish speaking, so flor translated her side effects to me. She stated that patient experienced severe Fatigue, fever, shivering, weakness and myalgia. She also stated that she felt pain in her shoulders, and numbness in legs. She was concerned as she perceived these side effects as something that was abnormal. She stated that she took Tylenol ,and the next day she felt a lot better, and the numbness in her feel has gotten a lot better as well improving on daily basis. I informed patient that what she was experiencing was the side effects that are associated with the shingles vaccine (as stated on facts & comparisons). I also advised her to make appointment with her doctor to do a follow up to make sure everything was ok with her to rule out any serious conditions.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed 2 lesions on her ear and stomach with a fever of 103F. Gradually the number of lesions increased to approximately 10-12. The lesions were mainly on her inner thighs, stomach and back of her legs.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 as dose 1, single (Lot number: EN6207), on 14Apr2021 as dose 2, single (Lot number: EW0161), on 27Oct2021 as dose 3 (booster), single (Lot number: FF2590) and on 01May2022 at 18:30 as dose 4 (booster), single (Lot number: FM7553) at the age of 63 years for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Lyme disease", start date: 2017, stop date: 2020; "adhd" (unspecified if ongoing); "depression" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "arthritis" (unspecified if ongoing); "spinal stenosis" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of Drug ineffective, covid-19.Product- COVID 19 Treatment, Brand- Paxlovid,Treatment start date- 26May2022,Treatment stop date- 31May2022,Indication- Treatment of COVID-19.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Shakiness-Mild, Additional Details: Patient felt dizzy, unstable upon standing, skin became pale, sweaty, cool and clammy. Hospital treated for potential shock - moved from sitting in chair to reclining position with legs elevated, cold compress applied to back of neck. BP was low upon initial reading, but improved to within normal limits after 10 minutes.  Patient remained under observation for additional 30 minutes.  Follow-up phone call to patient's mother (patient is minor) by hospital, mother reported no additional problems
PULMONARY EMBOLISM; This spontaneous report received from a patient via a company representative via social media (J and J corporate) concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had never been on blood thinners before the vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced pulmonary embolism. It was reported as "I had the Johnson and Johnson vaccine. Afterwards I got a pulmonary embolism. I never had been on blood thinners before and now I will be forever" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pulmonary embolism was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20221161615- pulmonary embolism. The event has an unknown/unclear temporal relationship, and is labeled. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.
Fever (highest of 102 degrees); severe body aches; severe chills; unable to sleep; This is a spontaneous report from a contactable consumer. This consumer reported for a 24-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EL9267; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 23Feb2021 (at age of 24-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Patient was not pregnant at time of vaccination. Patient's medical history was none. Patient had not other medical history nor any known allergies. Concomitant medications included escitalopram oxalate (LEXAPRO) and levothyroxine sodium (SYNTHROID) taken for an unspecified indication. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EL3249; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 26Jan2021 (at age of 23-years-old) for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient had not COVID prior vaccination. On 24Feb2021 12:00 the patient experienced fever, severe body aches, severe chills and unable to sleep. Patient did not receive any treatment for AEs. Patient had not tested for COVID post vaccination. The patient underwent lab tests and procedures which included body temperature: highest of 102 degrees on unspecified date. The outcome of all events was recovering.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
This is a rash on her left arm encircling this spot check the vaccine Covid 19 and she had the vaccine 1 week ago in the retroperitoneum a day or 2 of that and is now fading away
Injection site became hard, rough, and warm to touch. Gradually expanded to approximately 5 inches diameter. Subsided after 3 days. Then reappeared about 7 days after injection, this time expanding to about 8 inches before subsiding after another 3 days.  Only mild soreness or sensitivity.
I woke up with a sore throat and a cough. I had a headache with sinus congestion, a fever that never went over 101. I had the chills as well and feeling very tired. For treatment, I was prescribed PAXLOVID on the 2nd day of the infection. On 12/07/2022, I wasn't really fully recovered and I had gotten COVID-19 again. It was much worse the 2nd time. I had the same symptoms except this time my fever had gone up to 103. My first infection lasted 3-4 days and the 2nd infection lasted about 2 weeks. The cough is still lingering. I had much more congestion and felt much more tired during the second infection. I didn't go back for a 2nd dose of PAXLOVID. I did test negative after 5 days the first time. I didn't test after the 2nd time because I hadn't left for 2 weeks. I didn't test during the 2nd time, but I was negative before I got it again. I was positive the 2nd time the first day of the symptoms. I wanted to make sure I didn't get the flu for the 2nd time.
Dull headache; This is a spontaneous report from a contactable consumer or other non HCP (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2 formulation; Solution for injection), dose 1 via an unspecified route of administration on 04Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included surgery (she takes aspirin 81 mg daily for a surgery she had in the past) from an unknown date and unknown if ongoing. Concomitant medication included acetylsalicylic acid (ASPIRIN 81) taken for surgery from an unspecified start date and ongoing. The patient stated that she began to experience a dull headache on 18Feb2021 and asking if it was good to take Tylenol. The patient also wanted to know if she should stop taking the aspirin. The patient scheduled to get her second dose on 25Feb2021. The outcome of the event was reported as unknown.  Follow-up attempts are completed. No further information is expected.
Within 24 hours patient experienced injection site pain, fatigue, headache, joint pain, chills, and fever. Employee took IBU and that helped.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 83-year-old female patient who received Shingrix (batch number G933B, expiry date 22nd November 2020) for prophylaxis. On 30th July 2018, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were provided as follows: The patient received the Shingrix on left arm. The pharmacist stated that, the patient had been experiencing sore arm since getting the dose of Shingrix vaccine. No further details were provided.
Presented to ED on  2/11/23 with vomiting. Was given a diagnosis of vomiting and sent home with ondansetron. Presented to ED again on 2/12/23. Was diagnosed with and admitted for intussusception of intestine.
PATIENT STATED THAT THEY TOOK OFF THE BAND-AID THE MORNING AFTER VACCINE ADMINISTRATION AND THERE WAS A BLISTER PRESENT UNDERNEATH THE BAND-AID. THE BLISTER POPPED AND HE PRESENTED TO THE PHARMACY WITH INFLAMMATION AND OPEN SKIN AT THE INJECTION SITE.
foster mom reported sz activity the noc p/vax & the next morning foster mom spoke w/MD on call over weekend;how ever child was not seen;
Felt worse than she did when she had COVID-19; Extremely light headed; Wasn't able to move; Vertigo; Trouble peeing; Headache; Had a 102 F fever; Chills; Unable to keep anything in; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt worse than she did when she had COVID-19), DIZZINESS (Extremely light headed), MOVEMENT DISORDER (Wasn't able to move), VERTIGO (Vertigo) and DYSURIA (Trouble peeing) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (In December). Concomitant products included FENOFIBRATE, UBIDECARENONE (COQ10 EXCEL), CALCIUM and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION COMPLICATION (Felt worse than she did when she had COVID-19), DIZZINESS (Extremely light headed), MOVEMENT DISORDER (Wasn't able to move), VERTIGO (Vertigo), DYSURIA (Trouble peeing), HEADACHE (Headache), PYREXIA (Had a 102 F fever), CHILLS (Chills) and VOMITING (Unable to keep anything in). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 07-Mar-2021, VACCINATION COMPLICATION (Felt worse than she did when she had COVID-19), DIZZINESS (Extremely light headed), MOVEMENT DISORDER (Wasn't able to move), PYREXIA (Had a 102 F fever) and VOMITING (Unable to keep anything in) had resolved. At the time of the report, VERTIGO (Vertigo), DYSURIA (Trouble peeing), HEADACHE (Headache) and CHILLS (Chills) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Parent report patient experienced a rash the evening of 9/12/19. He was given vaccines on 9/11/19. Rash was on his trunk, front and back, extending down to groin. Rash spared arms, face, buttocks and lower extremities.
Client said he received a pneumonia injection yesterday. This morning his left arm is swollen from close to his shoulder down to his elbow. The area is red, painful 8/10, and hot, and his temperature is 101. His mouth is dry, but, not swollen, client said. Client was advised the ER. 1/25/2014 Emergency Dept: cellulitis vs erysipelas, ROCEPHIN 1 gm in ED, TORADOL 60 mg IM for pain, follow up in ED in AM for further evaluation and care. 1/26/2014 Emergency Department: 74 year old male who presents to the Emergency Dept. for F/U cellulitis. Was seen in ER yesterday, received one dose ceftriaxone. Pt feeling much better, able to bend arm, no fever today. Still has pain. No drainage. No significant increase in redness. Cellulitis vs erysipelas. Condition on discharge: Stable. Plan/Instructions: - will treat with KEFLEX and BACTRIM. F/U with PCP in 3-4 days. 1/27/2014 Emergency Dept: pt was seen on 1/25 and given a gram of ROCEPHIN; returned 1/26 and started on KEFLEX and SEPTRA; pt denies any fever since 102 on Saturday, states that he can move the arm better than on Saturday; denies any itching or burning sensation. Admitted as inpatient for left upper arm pain/redness/swelling and fever since he received a pneumonia shot to his left deltoid last Friday. Temperature has been as high as 102 degrees F; patient has not taken any additional medication except for 50 mg of BENADRYL on Friday night. Patient states that area of erythema has been growing, ROM is limited in the affected arm. Current pain level is 5/10 with movement; there is no pain without it. He denies chest pain, dyspnea, difficulty swallowing, and other organic symptoms. Ceftriaxone 1 gm once, ketorolac tromethamine 60 mg once, cephalexin 500 mg QID.
Patient was given the orange top Covid 19 Pfizer 5-11 years 0.3 ml undiluted solution . No adverse reaction reported at this time.  Pt was due for Covid 19 Pfizer gray top 12 plus years vaccine, monovalent 2nd dose
pt recvd vax; devel fever & had prolonged sz;required intubation & transferred to hosp for intensive care tx;
The injection site was red, raised, warm to the touch.; The injection site was red, raised, warm to the touch.; The injection site was red, raised, warm to the touch.; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 21-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EK9231/expiration date: not provided), via intramuscular route of administration, on 04Jan2021 01:00 PM (at the age of 21 years old) as a single dose in the left arm for COVID-19 vaccination. Relevant medical history included heart murmur. The patient has an allergy to sulfa. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unspecified date. Concomitant medication included atenolol, spironolactone, and alprazolam (XANAX). The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Jan2021 at 12:00 AM, the patient experienced the injection site was red, raised, warm to the touch. The patient did not receive any treatment for these events. The outcome of the events the injection site was red, raised, warm to the touch was recovering. Since the vaccination, the patient had not been tested for COVID-19.